Piyush K. Agarwal, M.D.
Urologic Oncology Branch
Building 10 - Hatfield CRC, Room 2-5952
Bethesda, MD 20892-1210
Dr. Agarwal is interested in targeted therapy for bladder cancer. One of his current projects is molecular targeted photoimmunotherapy in bladder cancer targeting EGFR, FGFR3, and other mutated and/or over-expressed surface receptors in urothelial cancer. This is in collaboration with Hisataka Kobayashi, M.D., Ph.D., and Peter L. Choyke, M.D. F.A.C.R. (Molecular Imaging Program). In addition, he is conducting a randomized phase II clinical trial for patients with high-grade bladder cancer who have failed at least 1 course of Baccillus Calmette-Guerin (BCG) that is looking at the efficacy of a vaccine combined with BCG. This study is in collaboration with James L. Gulley, M.D., Ph.D. (Genitourinary Malignancies Branch) and Jeffrey Schlom, Ph.D. (Laboratory of Tumor Immunology and Biology).
Weintraub MD, Li QQ, Agarwal PK. Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review). Mol Clin Oncol. 2014;2(5):656-660.
Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, Redorta JP, Rha KH, Richstone L, Saar M, Scherr DS, Siemer S, Stoeckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M, Khan MS. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2014;65(2):340-7.
Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS. Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States. Urol Oncol. 2014;32(5):637-44.
Park JC, Citrin DE, Agarwal PK, Apolo AB. Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014;38(3):80-108.
Ghosh M, Brancato SJ, Agarwal PK, Apolo AB. Targeted therapies in urothelial carcinoma. Curr Opin Oncol. 2014;26(3):305-20.